Academic Medicine Scholars Program, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA.
Department of PA Studies, New York Institute of Technology School of Health Professions, Old Westbury, NY, USA.
J Osteopath Med. 2022 Jan 12;122(3):153-157. doi: 10.1515/jom-2021-0189.
Pfizer-BioNTech BNT162b2 is one of the three U.S. Food and Drug Administration (FDA)-approved vaccines for the prevention of COVID-19. Its most common side effect, injection site pain, occurs because of locally recruited inflammatory mediators and is mitigated by the lymphatic system. Side effects may discourage individuals from receiving vaccines; therefore, reducing the duration of injection site pain can promote vaccination compliance. Osteopathic manipulative treatments (OMT) can directly affect the physiology underlying muscle soreness; however, there is currently no literature that supports the use of OMT in this scenario. In this case report, an otherwise healthy male presented with acute left deltoid soreness after receiving the Pfizer COVID-19 vaccine. The pain began 5 h prior to the visit. Three hours after being treated with lymphatic OMT, the severity of the pain was significantly reduced and was alleviated 8h after onset in comparison to the median duration of 24-48 h. He received his second dose 3 weeks later. This case report can provide future studies with the groundwork for further investigating the role of OMT in treating postvaccination muscle soreness, which can improve patient satisfaction and potentially promote vaccination compliance.
辉瑞-生物技术公司的 BNT162b2 是美国食品和药物管理局（FDA）批准的三种 COVID-19 预防疫苗之一。其最常见的副作用，即注射部位疼痛，是由于局部募集的炎症介质引起的，可被淋巴系统缓解。副作用可能会使个人不愿意接种疫苗；因此，减少注射部位疼痛的持续时间可以提高疫苗接种的依从性。整骨疗法的手法治疗（OMT）可以直接影响肌肉酸痛的生理基础；然而，目前没有文献支持在这种情况下使用 OMT。在本病例报告中，一名健康男性在接种辉瑞 COVID-19 疫苗后出现急性左三角肌疼痛。疼痛始于就诊前 5 小时。在接受淋巴 OMT 治疗 3 小时后，疼痛的严重程度显著减轻，与中位数持续时间 24-48 小时相比，在发病后 8 小时得到缓解。他在 3 周后接受了第二剂。本病例报告可以为未来的研究提供基础，进一步探讨 OMT 在治疗接种后肌肉酸痛中的作用，这可以提高患者的满意度，并有可能提高疫苗接种的依从性。
